Search Within
Document Type
112-90-3
Applied Filters:
Keyword:'112-90-3'
Showing 1-30 of 289 results for "112-90-3" within Technical Documents
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
105 70 110 66 84 111
1:16 dil 129 84 42 108 87 90 94 61 83 100 64 114 61 75 116
Average 121 84 49 107 95 93 94 66 87 104 69 110 68 83
The Effective Use of Protein Kinase Inhibitors
104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93 79 94 103
69
109 20 105 86 90 3 3 96 89 71 93 76 94 96
7
Verfication summary-03-0202-00
2822621
3 MRD (1:2) 56.40 1.0 2% 112.80 1.0 1% -
3 1:4 31.71 1.1 3% 126.84 1.1 1% 112%
3 1:8 15.82 1.0 6% 126.59 1.0 1% 112%
3 1:16 8.04 0.1 2% 128.61 0.1 0% 114%
Verfication summary-03-0202-00
2822621
3 MRD (1:2) 56.40 1.0 2% 112.80 1.0 1% -
3 1:4 31.71 1.1 3% 126.84 1.1 1% 112%
3 1:8 15.82 1.0 6% 126.59 1.0 1% 112%
3 1:16 8.04 0.1 2% 128.61 0.1 0% 114%
NovAseptic Valve: Valve Body, Tank Outlet Valve 90°, Elbow 90° TC, Part No: NU###/441-312
3.583) NU300 3"
76.2x1.65
(3.0x0.065)
NovAseptic® Valve
Valve Body, Tank Outlet Valve 90˚, Elbow 90˚ TC
Catalogue Number NU###/441-312
Valve Body, Tank Outlet Valve 90˚, Elbow 90˚ TC Configuration
The Effective Use of Protein Kinase Inhibitors
104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93 79 94 103
69
109 20 105 86 90 3 3 96 89 71 93 76 94 96
7
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
Control 1 112 – 232 pg/mL IL-9 Control 1 111 – 231 pg/mL
Control 2 559 – 1161 pg/mL Control 2 533 – 1107 pg/mL
Product Information Sheet - T6791
Oxford / Chichester, UK), Chapter 4,
Section 1, pp. 89-90 (2014).
6. Wanders, R.J.A. et al., J. Inherit. Metab. Dis.,
18(Suppl. 1), 101-112 (1995).
Trizma is a registered trademark of Sigma-
NovAseptic Valve: Valve Body, Shut off 90° TC, Part No: NA##/31-212 and NU###/31-212
) NA76 76.2x1.65 NU300 3"
76.2x1.65
(3.0x0.065)
NovAseptic® Valve
Valve Body, Shut off 90˚ TC
Catalogue Number NA##/31-212 and NU###/31-212
Valve Body, Shut off 90˚ TC Configuration
Specification
NovAseptic Valve: Valve Body, Tank Outlet Valve 180°, Elbow 90° TC, Part No: NU###/451-312
20µin)
External surface Ra ≤ 1.6µm (63µin)
Design Temperature, Valve Body: -80 to 200 ºC (-112 to 392 ºF)
Design Pressure, Valve Body: -1 to 10 bar(g) (-14.5
NovAseptic Valve: Valve Body, Tank Outlet Valve 180°, Elbow 90°, Part No: NU###/451-311
0.394) NU300 3"
76.2x1.65
(3.0x0.065)
NovAseptic® Valve
Valve Body, Tank Outlet Valve 180˚, Elbow 90˚
Catalogue Number NU###/451-311
Valve Body, Tank Outlet Valve 180˚, Elbow 90˚ Configuration
NovAseptic Valve: Valve Body, Tank Outlet Valve 90°, Elbow 90°, Part No: NU###/441-311
(15 μin)
External surface Ra ≤ 1.6 μm (63 μin)
Design Temperature, Valve Body –80 to 200 ºC (–112 to 392 ºF)
Design Pressure, Valve Body –1.03 to 10 bar(g) (–15 to 145 psi(g))
Note The
Data Sheet - C9774 - Lot 076K8807
requirements Pass
Specific rotation, [α]D25
5 mg/ml solution in alcohol
between +105° and +112° +108°
Assay high pressure
liquid chromatography
not less than 97.0% and not more than
Data Sheet - R8157 - Lot 109K0794
mM
NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: ∼112 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 459–621 nmole/min/mg (see Figure
Data Sheet - M8698
sulfoxide reductase restores ability to
activate the plasma membrane Ca-ATPase.
Biochemistry, 38, 105–112 (1999).
5. Davis, D.A., et al., HIV-2 protease is inactivated
after oxidation at the dimer interface
Product Information Sheet - C2882
formula:C27H48O
Molecular weight: 388.67
[α]D (C = 1 in chloroform): 29.5-32.5°
Melting point: 108-112 °C
5β-Cholestan-3α-ol (epicoprostanol) belongs to the
family of sterols with saturated side chains
NovAseptic®Mixer: Tank Plate, GMP ATEX Specification
1.50)
— 18
(0.71)
44
(1.73)
M6 45º 50
(1.97)
— 3
(0.12)
1
(0.04)
2.5
(0.10)
GMP50 ATEX
AX1/33 54
(2.13)
90
(3.54)
58
(2.28)
50
(1.97)
Data Sheet - H157
receptor antagonist, HOE 140, in
isolated blood vessels from different species. Br. J.
Pharmacol., 112, 683-689 (1994).
Wirth, K., et al., Hoe 140, a new potent and long acting
bradykinin antagonist:
NovAseptic Valve: Valve Body, Shut off 90°, TC connectable, Part No: NA##/371-211 and NU###/371-211
240µ-in]
External surface Ra [ 1,6µm [63µ-in]
Design Temperature, Valve Body:
-80°C to 200°C [-112°F to 392°F]
Design Pressure, Valve Body:
-1 to 10 bar(g) [-14.5psi to 101.5psi]
Note!
Data Sheet - V3639
trichlorocarbanilide in control
of the protonmotive force in Escherichia coli cells.
Biochem. J., 212, 105-112 (1983).
5. Davidson, G.A., and Berma, M.C., Interaction of
valinomycin and monovalent cations with
Data Sheet - SAE0022
different genes. In most cell types the PGM1
isozyme is predominant, representing about 90% of
total PGM activity.3 Native PGM1 is known to be post-
translationally modified by cytoplasmic glycosylation
Data Sheet - R8157
NaCl, 0.25 mM DTT, 0.1 mM EGTA, 0.1 mM EDTA,
0.1 mM PMSF, and 25% glycerol.
Molecular mass: 112 kDa
Precautions and Disclaimer
This product is for R&D use only, not for drug,
household, or
NovAseptic Valve: Valve Body, Shut off 90°, TC connectable, Part No: NU###/4710-221
μin)
External surface Ra ≤ 1.6 μm (63 μin)
Design Temperature,
Valve Body
–80 to 200 ºC (–112 to 392 ºF)
Design Pressure,
Valve Body
–1 to 10 bar(g) (–14.5 to 145 psi(g))
NovAseptic®Mixer, Tank Plate, GMP and HS
—
18
(0.71)
44
(1.73) M6 45º
50
(1.97) —
3
(0.12)
1
(0.04)
2.5
(0.10)
GMP 50, HS
T10 & USM T10
GM1/33 54 (2.13)
90
(3.54)
58
Cinalukast (Ro 24-5913)- subtype selective orally active cysteinyl leukotriene (CysLT1) receptor antagonist
al., Clin. Exp. Allergy, 33, 1380-1388 (2003).
2. Kawano, T., J. Allergy Clin. Immunol., 112, 369-374 (2003).
3. Hui, Y. and Funk, C.D., Biochem. Pharmacol., 64, 1549-1157 (2002).
4. O’Donnell, M., et
Data Sheet - A1858 - Lot 118K0523
glycerol.
Molecular mass: ∼60 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 82–112 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
Data Sheet - A1858 - Lot 010M0846
glycerol.
Molecular mass: ∼60 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 82–112 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
Data Sheet - A1858 - Lot 029K0696
glycerol.
Molecular mass: ∼60 kDa
Purity: ≥70% (SDS-PAGE, see Figure 1)
Specific Activity: 82–112 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use only, not for
Data Sheet - SAB4200250
titration.
References
1. Karagogeos, D., et al., Development, 112, 51-67
(1991).
2. Traka, M., et al., J. Neurosci., 22, 3016-3024
(2002).
3. Law, C.O., et al., Development, 135, 2361-2371
(2008
Data Sheet - A3851
5007 (2002).
2. Bohm, B.B., et al., Arthritis Rheum., 44, 46-54
(2001).
3. Nath, D., et al., J. Cell Sci., 112, 579-587 (1999).
kaa 12/02
Sigma brand products are
Page 1 of 10